November 22, 2019 Allogene and the need for a reliable cell source A recent technology deal with Notch points to a problem that all allogeneic cell therapy players might sooner or later have to tackle.
October 07, 2019 Venture cash gets even more concentrated The latest venture capital numbers suggest that 2019 will see a healthy amount raised, but the falling number of rounds could be a worry.
